Biotech & Pharmaceutical Issues in China
On January 28, 2013 Fordham and Jones Day sponsored a one-day conference on Biotech & Pharmaceutical Issues in China, which explored current topics in one of the hottest growth sectors within one of the world’s dominant economies.
AGENDA
8:50–9 a.m
Opening Comments
Sheila Foster, Vice Dean, Fordham Law
9–10 a.m.
WHERE ARE PHARMA AND BIOTECH HEADED IN CHINA?
– Role of China in the global pharmaceutical innovation value chain
– Market opportunities in China for pharmaceutical innovators
– Competition landscape and dynamic interaction of global and local players in China’s pharmaceutical market
Speakers
Roy Zwahlen, Legal & Policy Specialist, Biotechnology Industry Organization
Representatives from the investment, consultant & academic research communities who are active in China
10–11 a.m.
INNOVATION POLICIES UNDER NEW POWER/POLICY IN CHINA
– Implementation of the 15-year science and technology plan and national IP strategy
– U.S. government engagement with China on life science IP policies
– SIPO/USPTO Cooperation
Speakers
Teresa Rea, Deputy Director, USPTO
Mark Cohen, Senior Counsel for China, USPTO (invited)
(For Teresa Stanek Rea’s remarks, please visit the following page: http://www.uspto.gov/about-us/news-updates/intellectual-property-trends-and-developments-china)
11 a.m.–noon
WIND OF CHANGE FOR PHARMACEUTICAL INNOVATORS
– New rules for compulsory patent license
– A new round of patent law amendment
– Draft rules for inventor remuneration
Speaker
Tony Chen, Partner, Jones Day
noon–2 p.m.
NETWORKING LUNCH & TWO-ACT PERFORMANCE:
“MR. BIG IN WONDERLAND”
A mock patent prosecution interview and a mock patent litigation in China.
2–3 p.m.
DRUG REGISTRATION AND IP PROTECTION
– Patent linkage in SFDA drug registration regime
– Data protection under China’s Drug Registration Regulation
– Monitoring Period Exclusivity
– Industry initiatives and future directions
Speaker
Alice Hu, Associate, Jones Day
3–4 p.m.
SIPO EXAMINATION AND INVALIDATION
– “You cannot visit the same SIPO twice”—Evolution of SIPO guidelines and impact on pharmaceutical patent grant rate
– “Speed up by slowing down”—A patent prosecution strategy for blockbuster drugs
– “Invalidation by straw man”—A peculiar patent troll phenomenon in China
Speaker
Tony Chen, Partner, Jones Day
4–5 p.m.
PHARMACEUTICAL PATENT LITIGATION IN CHINA
– A tale of two venues: PRB & Intermediate Court
– Evidence collection & burden of proof
– Bolar exemption and definitive defense to patent infringement
Speaker
Yang Xu, Chief Patent Counsel, Simcere Pharmaceuticals